Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study
- PMID: 37775293
- PMCID: PMC10546149
- DOI: 10.1136/bmjopen-2023-075413
Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study
Abstract
Objective: Our study aimed to explore the diagnostic value of triglyceride-glucose (TyG) and its related parameters in metabolism-associated fatty liver disease (MAFLD).
Design: A cross-sectional study of residents who attended medical checkups at the First Hospital of Nanping City, Fujian Medical University, between 2015 and 2017.
Setting: One participation centre.
Participants: 2605 subjects met the inclusion-exclusion criteria and were grouped according to whether they had MAFLD.
Results: The TyG index and its associated parameters are positively associated with the risk of developing MAFLD (p<0.001). Restriction cube spline analysis showed a significant dose-response relationship between the TyG index and MAFLD. The risk of developing MAFLD increases significantly with a higher TyG index. After adjusting for confounders, this relationship remains (OR: 4.89, 95% CI 3.98 to 6.00). The areas under the receiver operating characteristic curves of the TyG index for MAFLD detection were 0.793 (0.774 to 0.812). The areas under the curve (AUC) of TyG-related parameters were improved, among which TyG-waist circumference (TyG-WC) showed the largest AUC for MAFLD detection (0.873, 95% CI 0.860 to 0.887). In addition, the best cut-off value of the TyG-WC was 716.743, with a sensitivity and specificity of 88.7% and 71.4%, respectively.
Conclusion: The TyG index effectively identifies MAFLD, and the TyG-related parameters improved the identification and diagnosis of MAFLD, suggesting that TyG-related parameters, especially TyG-WC, may be a useful marker for diagnosing MAFLD.
Keywords: epidemiology; hepatology; lipid disorders.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Correlation analysis of the triglyceride-glucose index and related parameters in metabolic dysfunction-associated fatty liver disease.Sci Rep. 2025 Jan 2;15(1):23. doi: 10.1038/s41598-024-84809-y. Sci Rep. 2025. PMID: 39748005 Free PMC article.
-
Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants.BMJ Open. 2023 May 2;13(5):e070189. doi: 10.1136/bmjopen-2022-070189. BMJ Open. 2023. PMID: 37130686 Free PMC article.
-
Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017-2020.BMC Gastroenterol. 2025 May 1;25(1):325. doi: 10.1186/s12876-025-03915-x. BMC Gastroenterol. 2025. PMID: 40312305 Free PMC article.
-
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.Front Endocrinol (Lausanne). 2022 Sep 2;13:951689. doi: 10.3389/fendo.2022.951689. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36120429 Free PMC article.
-
Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.Front Endocrinol (Lausanne). 2024 Jan 22;14:1308265. doi: 10.3389/fendo.2023.1308265. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38317718 Free PMC article.
Cited by
-
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675. World J Hepatol. 2025. PMID: 40747230 Free PMC article. Review.
-
Nonlinear relationship between TyG index and the risk of non-alcoholic fatty liver disease in Chinese population: a cross-sectional study.Am J Transl Res. 2025 Jun 15;17(6):4315-4322. doi: 10.62347/EXFN1219. eCollection 2025. Am J Transl Res. 2025. PMID: 40672596 Free PMC article.
-
Fatty Liver Index vs. Biochemical-Anthropometric Indices: Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease with Non-Invasive Tools.Diagnostics (Basel). 2025 Feb 26;15(5):565. doi: 10.3390/diagnostics15050565. Diagnostics (Basel). 2025. PMID: 40075812 Free PMC article.
-
Correlation analysis of the triglyceride-glucose index and related parameters in metabolic dysfunction-associated fatty liver disease.Sci Rep. 2025 Jan 2;15(1):23. doi: 10.1038/s41598-024-84809-y. Sci Rep. 2025. PMID: 39748005 Free PMC article.
-
A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach.Hepatol Int. 2025 Aug;19(4):820-835. doi: 10.1007/s12072-025-10792-9. Epub 2025 Apr 9. Hepatol Int. 2025. PMID: 40205303
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous